What We Learned From Plasma BK-Virus Monitoring in Allogeneic Hematopoietic Transplant Recipients

Transplantation. 2016 Apr;100(4):e17-8. doi: 10.1097/TP.0000000000001103.
No abstract available

Publication types

  • Letter

MeSH terms

  • BK Virus / genetics*
  • BK Virus / immunology
  • Biomarkers / blood
  • Capsid Proteins / blood
  • Capsid Proteins / genetics*
  • Cystitis / blood
  • Cystitis / virology
  • DNA, Viral / blood
  • DNA, Viral / genetics*
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hemorrhage / blood
  • Hemorrhage / virology
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Opportunistic Infections / blood
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / immunology
  • Opportunistic Infections / virology*
  • Polymerase Chain Reaction
  • Polyomavirus Infections / blood
  • Polyomavirus Infections / diagnosis
  • Polyomavirus Infections / immunology
  • Polyomavirus Infections / virology*
  • Predictive Value of Tests
  • Prospective Studies
  • Time Factors
  • Transplantation, Homologous
  • Tumor Virus Infections / blood
  • Tumor Virus Infections / diagnosis
  • Tumor Virus Infections / immunology
  • Tumor Virus Infections / virology*
  • Viral Load

Substances

  • Biomarkers
  • Capsid Proteins
  • DNA, Viral
  • Immunosuppressive Agents
  • VP1 protein, polyomavirus